Cholangiocarcinoma
Author:
Funder
US National Institutes of Health
Publisher
Elsevier BV
Subject
General Medicine
Reference141 articles.
1. Combination of gemcitabine and cisplatin for biliary tract cancer: a platform to build on;Razumilava;J Hepatol,2011
2. Pathological classification of intrahepatic cholangiocarcinoma based on a new concept;Nakanuma;World J Hepatol,2010
3. Cholangiocarcinoma: advances in pathogenesis, diagnosis, and treatment;Blechacz;Hepatology,2008
4. Cholangiocarcinoma: thirty-one-year experience with 564 patients at a single institution;DeOliveira;Ann Surg,2007
5. Histological diversity in cholangiocellular carcinoma reflects the different cholangiocyte phenotypes;Komuta;Hepatology,2012
Cited by 1411 articles. 订阅此论文施引文献 订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. Immunotherapeutic strategies in hepatopancreatobiliary cancers;Principles of Immunotherapy Breast and Gastrointestinal Cancers;2025
2. Survival analysis and prognostic nomogram for patients with cholangiocarcinoma after radical resection in Asia;European Journal of Surgical Oncology;2024-12
3. Effect of photodynamic therapy on peripheral immune system for unresectable cholangiocarcinoma;Photodiagnosis and Photodynamic Therapy;2024-10
4. Unraveling the crosstalk: circRNAs and the wnt signaling pathway in cancers of the digestive system;Non-coding RNA Research;2024-09
5. Transforming pancreaticobiliary cancer treatment: Exploring the frontiers of adoptive cell therapy and cancer vaccines;Molecular Therapy: Oncology;2024-09
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3